A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01591512

Enrollment

Registered

2012-05-04

Start date

2011-05-31

Completion date

2012-07-31

Last updated

2015-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Cell Lung Cancer

Keywords

Small Cell Lung Cancer, SCLC, Lung Cancer, Subjects diagnosed with SCLC who will undergo treatment

Brief summary

The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18 * Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results * Scheduled to undergo first-, second- or third-line treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy. * Able to understand and willing to provide Informed Consent

Exclusion criteria

* No diagnosis of SCLC * Not scheduled to undergo treatment for the diagnosis of SCLC * Unable to provide Informed Consent

Countries

United States

Outcome results